Implementation and evaluation of specialist heart failure pharmacist prescribing clinics

Medications form the basis of treatment for heart failure (HF) and adherence is crucial as untreated HF has a mortality of greater than 30%. As such, specialist HF pharmacists with expertise in prescribing and promoting adherence have become an integral part of the wider HF multidisciplinary team (M...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical pharmacy 2024-10
Main Authors: Campbell, Gayle, Doherty, Ciara, D'Silva, Andrew, Carr-White, Gerald, Webb, Jessica, Ismail, Tevfik F
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c228t-cd62459bdc72f16aaa73b4e0bd5af713ee75860e71fced9ece6d69295bd7a4523
container_end_page
container_issue
container_start_page
container_title International journal of clinical pharmacy
container_volume
creator Campbell, Gayle
Doherty, Ciara
D'Silva, Andrew
Carr-White, Gerald
Webb, Jessica
Ismail, Tevfik F
description Medications form the basis of treatment for heart failure (HF) and adherence is crucial as untreated HF has a mortality of greater than 30%. As such, specialist HF pharmacists with expertise in prescribing and promoting adherence have become an integral part of the wider HF multidisciplinary team (MDT). To implement specialist HF pharmacist prescribing clinics and evaluate their impact. An integrated HF team at a tertiary London hospital. The clinic was initially developed to facilitate the introduction of sacubitril-valsartan evolving to 6 dedicated clinics/week. A dedicated electronic referral pathway was created to channel referrals to the specialist clinic, and referral criteria expanded to all patients requiring optimisation of medical therapy. Data were retrospectively collected for patients with heart failure with reduced ejection fraction seen in the HF pharmacist clinic between September 2021 and July 2022. Overall, 114 patients were seen (mean age 66 years, 78 male). The mean time to medication optimisation was 3 months (averaging 1 appointment/month). The number on optimised doses of guideline-directed medical therapy, increased significantly from 8% at first appointment to 76% on discharge (p 
doi_str_mv 10.1007/s11096-024-01808-9
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3113380542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3113380542</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-cd62459bdc72f16aaa73b4e0bd5af713ee75860e71fced9ece6d69295bd7a4523</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhC0EolXpH-CAcuQS8Ct2fEQVL6kSF5C4WRtnQ42cB3aCxL-npaV72R3tzBw-Qi4ZvWGU6tvEGDUqp1zmlJW0zM0JmXPOaK41Y6fHm4oZWab0SbcjFWeFPCczYYQqqeRz8v7cDgFb7EYYfd9l0NUZfkOY9rJvsjSg8xB8GrMNQhyzBnyYImbDBmILbvcYIiYXfeW7j8wF33mXLshZAyHh8rAX5O3h_nX1lK9fHp9Xd-vccV6OuasVl4Wpaqd5wxQAaFFJpFVdQKOZQNRFqShq1jisDTpUtTLcFFWtQRZcLMj1vneI_deEabStTw5DgA77KVnBmBAlLeTOyvdWF_uUIjZ2iL6F-GMZtTuodg_VbqHaP6jWbENXh_6parE-Rv4Ril-lqnQb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3113380542</pqid></control><display><type>article</type><title>Implementation and evaluation of specialist heart failure pharmacist prescribing clinics</title><source>Springer Nature</source><creator>Campbell, Gayle ; Doherty, Ciara ; D'Silva, Andrew ; Carr-White, Gerald ; Webb, Jessica ; Ismail, Tevfik F</creator><creatorcontrib>Campbell, Gayle ; Doherty, Ciara ; D'Silva, Andrew ; Carr-White, Gerald ; Webb, Jessica ; Ismail, Tevfik F</creatorcontrib><description>Medications form the basis of treatment for heart failure (HF) and adherence is crucial as untreated HF has a mortality of greater than 30%. As such, specialist HF pharmacists with expertise in prescribing and promoting adherence have become an integral part of the wider HF multidisciplinary team (MDT). To implement specialist HF pharmacist prescribing clinics and evaluate their impact. An integrated HF team at a tertiary London hospital. The clinic was initially developed to facilitate the introduction of sacubitril-valsartan evolving to 6 dedicated clinics/week. A dedicated electronic referral pathway was created to channel referrals to the specialist clinic, and referral criteria expanded to all patients requiring optimisation of medical therapy. Data were retrospectively collected for patients with heart failure with reduced ejection fraction seen in the HF pharmacist clinic between September 2021 and July 2022. Overall, 114 patients were seen (mean age 66 years, 78 male). The mean time to medication optimisation was 3 months (averaging 1 appointment/month). The number on optimised doses of guideline-directed medical therapy, increased significantly from 8% at first appointment to 76% on discharge (p &lt; 0.001). The HF pharmacists reviewed all medications and optimised non-HF medications for 17.5% (n = 20) of patients. HF pharmacists can optimise patients' HF and non-HF medical therapy typically within 3 months. By reviewing all prescribed medications, HF pharmacists provide a holistic review of all medications. They can play a vital role in addressing the underutilisation of HF medical therapy and thereby improving patient outcomes.</description><identifier>ISSN: 2210-7703</identifier><identifier>ISSN: 2210-7711</identifier><identifier>EISSN: 2210-7711</identifier><identifier>DOI: 10.1007/s11096-024-01808-9</identifier><identifier>PMID: 39368042</identifier><language>eng</language><publisher>Netherlands</publisher><ispartof>International journal of clinical pharmacy, 2024-10</ispartof><rights>2024. The Author(s).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-cd62459bdc72f16aaa73b4e0bd5af713ee75860e71fced9ece6d69295bd7a4523</cites><orcidid>0000-0002-8700-1545 ; 0000-0002-1691-7599 ; 0000-0001-6249-8797</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39368042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campbell, Gayle</creatorcontrib><creatorcontrib>Doherty, Ciara</creatorcontrib><creatorcontrib>D'Silva, Andrew</creatorcontrib><creatorcontrib>Carr-White, Gerald</creatorcontrib><creatorcontrib>Webb, Jessica</creatorcontrib><creatorcontrib>Ismail, Tevfik F</creatorcontrib><title>Implementation and evaluation of specialist heart failure pharmacist prescribing clinics</title><title>International journal of clinical pharmacy</title><addtitle>Int J Clin Pharm</addtitle><description>Medications form the basis of treatment for heart failure (HF) and adherence is crucial as untreated HF has a mortality of greater than 30%. As such, specialist HF pharmacists with expertise in prescribing and promoting adherence have become an integral part of the wider HF multidisciplinary team (MDT). To implement specialist HF pharmacist prescribing clinics and evaluate their impact. An integrated HF team at a tertiary London hospital. The clinic was initially developed to facilitate the introduction of sacubitril-valsartan evolving to 6 dedicated clinics/week. A dedicated electronic referral pathway was created to channel referrals to the specialist clinic, and referral criteria expanded to all patients requiring optimisation of medical therapy. Data were retrospectively collected for patients with heart failure with reduced ejection fraction seen in the HF pharmacist clinic between September 2021 and July 2022. Overall, 114 patients were seen (mean age 66 years, 78 male). The mean time to medication optimisation was 3 months (averaging 1 appointment/month). The number on optimised doses of guideline-directed medical therapy, increased significantly from 8% at first appointment to 76% on discharge (p &lt; 0.001). The HF pharmacists reviewed all medications and optimised non-HF medications for 17.5% (n = 20) of patients. HF pharmacists can optimise patients' HF and non-HF medical therapy typically within 3 months. By reviewing all prescribed medications, HF pharmacists provide a holistic review of all medications. They can play a vital role in addressing the underutilisation of HF medical therapy and thereby improving patient outcomes.</description><issn>2210-7703</issn><issn>2210-7711</issn><issn>2210-7711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kEtPwzAQhC0EolXpH-CAcuQS8Ct2fEQVL6kSF5C4WRtnQ42cB3aCxL-npaV72R3tzBw-Qi4ZvWGU6tvEGDUqp1zmlJW0zM0JmXPOaK41Y6fHm4oZWab0SbcjFWeFPCczYYQqqeRz8v7cDgFb7EYYfd9l0NUZfkOY9rJvsjSg8xB8GrMNQhyzBnyYImbDBmILbvcYIiYXfeW7j8wF33mXLshZAyHh8rAX5O3h_nX1lK9fHp9Xd-vccV6OuasVl4Wpaqd5wxQAaFFJpFVdQKOZQNRFqShq1jisDTpUtTLcFFWtQRZcLMj1vneI_deEabStTw5DgA77KVnBmBAlLeTOyvdWF_uUIjZ2iL6F-GMZtTuodg_VbqHaP6jWbENXh_6parE-Rv4Ril-lqnQb</recordid><startdate>20241005</startdate><enddate>20241005</enddate><creator>Campbell, Gayle</creator><creator>Doherty, Ciara</creator><creator>D'Silva, Andrew</creator><creator>Carr-White, Gerald</creator><creator>Webb, Jessica</creator><creator>Ismail, Tevfik F</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8700-1545</orcidid><orcidid>https://orcid.org/0000-0002-1691-7599</orcidid><orcidid>https://orcid.org/0000-0001-6249-8797</orcidid></search><sort><creationdate>20241005</creationdate><title>Implementation and evaluation of specialist heart failure pharmacist prescribing clinics</title><author>Campbell, Gayle ; Doherty, Ciara ; D'Silva, Andrew ; Carr-White, Gerald ; Webb, Jessica ; Ismail, Tevfik F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-cd62459bdc72f16aaa73b4e0bd5af713ee75860e71fced9ece6d69295bd7a4523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campbell, Gayle</creatorcontrib><creatorcontrib>Doherty, Ciara</creatorcontrib><creatorcontrib>D'Silva, Andrew</creatorcontrib><creatorcontrib>Carr-White, Gerald</creatorcontrib><creatorcontrib>Webb, Jessica</creatorcontrib><creatorcontrib>Ismail, Tevfik F</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campbell, Gayle</au><au>Doherty, Ciara</au><au>D'Silva, Andrew</au><au>Carr-White, Gerald</au><au>Webb, Jessica</au><au>Ismail, Tevfik F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implementation and evaluation of specialist heart failure pharmacist prescribing clinics</atitle><jtitle>International journal of clinical pharmacy</jtitle><addtitle>Int J Clin Pharm</addtitle><date>2024-10-05</date><risdate>2024</risdate><issn>2210-7703</issn><issn>2210-7711</issn><eissn>2210-7711</eissn><abstract>Medications form the basis of treatment for heart failure (HF) and adherence is crucial as untreated HF has a mortality of greater than 30%. As such, specialist HF pharmacists with expertise in prescribing and promoting adherence have become an integral part of the wider HF multidisciplinary team (MDT). To implement specialist HF pharmacist prescribing clinics and evaluate their impact. An integrated HF team at a tertiary London hospital. The clinic was initially developed to facilitate the introduction of sacubitril-valsartan evolving to 6 dedicated clinics/week. A dedicated electronic referral pathway was created to channel referrals to the specialist clinic, and referral criteria expanded to all patients requiring optimisation of medical therapy. Data were retrospectively collected for patients with heart failure with reduced ejection fraction seen in the HF pharmacist clinic between September 2021 and July 2022. Overall, 114 patients were seen (mean age 66 years, 78 male). The mean time to medication optimisation was 3 months (averaging 1 appointment/month). The number on optimised doses of guideline-directed medical therapy, increased significantly from 8% at first appointment to 76% on discharge (p &lt; 0.001). The HF pharmacists reviewed all medications and optimised non-HF medications for 17.5% (n = 20) of patients. HF pharmacists can optimise patients' HF and non-HF medical therapy typically within 3 months. By reviewing all prescribed medications, HF pharmacists provide a holistic review of all medications. They can play a vital role in addressing the underutilisation of HF medical therapy and thereby improving patient outcomes.</abstract><cop>Netherlands</cop><pmid>39368042</pmid><doi>10.1007/s11096-024-01808-9</doi><orcidid>https://orcid.org/0000-0002-8700-1545</orcidid><orcidid>https://orcid.org/0000-0002-1691-7599</orcidid><orcidid>https://orcid.org/0000-0001-6249-8797</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2210-7703
ispartof International journal of clinical pharmacy, 2024-10
issn 2210-7703
2210-7711
2210-7711
language eng
recordid cdi_proquest_miscellaneous_3113380542
source Springer Nature
title Implementation and evaluation of specialist heart failure pharmacist prescribing clinics
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T16%3A02%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implementation%20and%20evaluation%20of%20specialist%20heart%20failure%20pharmacist%20prescribing%20clinics&rft.jtitle=International%20journal%20of%20clinical%20pharmacy&rft.au=Campbell,%20Gayle&rft.date=2024-10-05&rft.issn=2210-7703&rft.eissn=2210-7711&rft_id=info:doi/10.1007/s11096-024-01808-9&rft_dat=%3Cproquest_cross%3E3113380542%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c228t-cd62459bdc72f16aaa73b4e0bd5af713ee75860e71fced9ece6d69295bd7a4523%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3113380542&rft_id=info:pmid/39368042&rfr_iscdi=true